超过5%股东持股披露「修订」
Cabaletta Bio(CABA)02-07 20:05
$Cabaletta Bio(CABA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001128 Act: 34 Size: 98 KB 网页链接
简介：Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发工程化T细胞疗法，这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的，也许是治疗性的治疗。
| 今开：10.46 | 昨收：10.48 |
| 最高：10.785 | 最低：10.14 |
| 涨停价： | 跌停价： |
| 总市值：513611829 |
Cabaletta Bio(CABA)02-07 20:05
$Cabaletta Bio(CABA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001128 Act: 34 Size: 98 KB 网页链接
Cabaletta Bio(CABA)03-05 06:55
$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025027 Size: 5 KB 网页链接
Cabaletta Bio(CABA)02-15 04:05
$Cabaletta Bio(CABA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000640 Act: 34 Size: 123 KB 网页链接
Cabaletta Bio(CABA)02-14 22:25
$Cabaletta Bio(CABA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001609 Act: 34 Size: 67 KB 网页链接
Cabaletta Bio(CABA)04-23 19:15
$Cabaletta Bio(CABA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-105890 Act: 34 Size: 162 KB 网页链接
Cabaletta Bio(CABA)04-23 19:05
$Cabaletta Bio(CABA)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-105870 Act: 34 Size: 624 KB 网页链接
Cabaletta Bio(CABA)02-14 07:55
$Cabaletta Bio(CABA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034084 Act: 34 Size: 49 KB 网页链接
Cabaletta Bio(CABA)02-15 09:55
$Cabaletta Bio(CABA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-024234 Act: 34 Size: 152 KB 网页链接
Cabaletta Bio(CABA)03-05 06:45
$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025002 Size: 5 KB 网页链接
Cabaletta Bio(CABA)03-05 06:55
$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025039 Size: 5 KB 网页链接
二麻麻04-08 22:02
$Cabaletta Bio(CABA)$
From Fred Alger Management: Cabaletta是一家临床阶段的生物技术公司，专注于发现和开发自身免疫性疾病的靶向细胞疗法。
该公司的主要候选药物 CABA-201 是一种治疗狼疮和肌炎的细胞疗法，美国食品和药物管理局已接受 CABA-201 的新药申请，为 1/2 期的初步读数...查看全文
guanwang5242023-09-06 09:24
$Cabaletta Bio(CABA)$ 这是一个庄家自娱自乐的股票查看全文
只抄右侧底2023-07-01 01:26
$Cabaletta Bio(CABA)$ 有去年10月$0.7 拿到今年2月$12 的兄弟姐妹么？出来说下心得。查看全文
guanwang5242023-01-31 23:17
$Cabaletta Bio(CABA)$ 美国最强的庄股，厉害啊，就是不敢做空它查看全文
guanwang5242023-01-27 23:58
$Cabaletta Bio(CABA)$ 一个庄家自娱自乐的股票查看全文
guanwang5242023-01-05 23:12
$Cabaletta Bio(CABA)$ 这个庄股厉害啊查看全文
guanwang5242022-12-29 23:25
$Cabaletta Bio(CABA)$ 美股庄股牛逼啊查看全文
guanwang5242022-12-23 22:25
$Cabaletta Bio(CABA)$ 会不会来个一天跌掉80%？查看全文
guanwang5242022-12-21 22:48
$Cabaletta Bio(CABA)$ 美国庄股厉害查看全文
产业链观察2022-10-11 19:19
药闻▶2022年10月11日，中国南京和上海，美国宾夕法尼亚州费城和加利福尼亚州圣何塞，——驯鹿生物（“IASO Bio”），一家处于临床阶段、致力于细胞创新药物开发的生物制药公司与$Cabaletta Bio(CABA)$ ，一家致力于针对自身免疫性疾病患者开发和商业化的首个靶向细胞疗法的临床阶段...查看全文
$Cabaletta Bio(CABA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-105890 Act: 34 Size: 162 KB 网页链接
$Cabaletta Bio(CABA)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-105900 Act: 34 Size: 3 MB 网页链接
$Cabaletta Bio(CABA)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-105870 Act: 34 Size: 624 KB 网页链接
$Cabaletta Bio(CABA)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001193125-24-073325 Act: 33 Size: 1 MB 网页链接
$Cabaletta Bio(CABA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-073318 Act: 33 Size: 55 KB 网页链接
$Cabaletta Bio(CABA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-034422 Act: 34 Size: 10 MB 网页链接
$Cabaletta Bio(CABA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-073294 Act: 34 Size: 224 KB 网页链接
$Cabaletta Bio(CABA)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-072048 Act: 34 Size: 178 KB 网页链接
$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025027 Size: 5 KB 网页链接
$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025039 Size: 5 KB 网页链接